| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director Of Accounting | Interim CFO
1 company
Herman Melanie J serves as a Director Of Accounting at LGND. Across recent SEC filings that breaks down to 0 buys and 5 sells. Those positions are worth an estimated $993K at current prices.
The biggest single holding is LGND (~$993K) as Director Of Accounting. The recent filings there lean toward selling, a net 13,223 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| May 18, 2016 | LGND Ligand Pharmaceuticals Inc | Director Of Accounting | Sell | 334 | $120.50 | $40,247.00 | -9.2% | |
| Nov 11, 2015 | LGND Ligand Pharmaceuticals Inc | Director Of Accounting | Sale+OE | 7,719 | $101.00 | $779,619.00 | -71.0% | |
| Jun 10, 2015 | LGND Ligand Pharmaceuticals Inc | Interim CFO | Sale+OE | 4,125 | $93.50 | $385,687.50 | -58.0% | |
| Mar 2, 2015 | LGND Ligand Pharmaceuticals Inc | Director Of Accounting | Sell | 535 | $60.69 | $32,469.15 | -15.2% | |
| Feb 19, 2015 | LGND Ligand Pharmaceuticals Inc | Director Of Accounting | Sell | 510 | $57.84 | $29,498.40 | -12.7% |